Anupam Rasayan completes acquisition of Mates Visa Consultancy, making it a wholly-owned subsidiary.
Anupam Rasayan India Limited acquired 100% of Mates Visa Consultancy Private Limited for ₹10,000 on July 17, 2026. This makes Mates Visa Consultancy a wholly-owned subsidiary. The acquisition is part of a group restructuring and supports the proposed acquisition of Bliss GVS Pharma Limited.
The acquisition is of a small consultancy firm for a minimal amount, but it is strategically positioned to support a larger acquisition (Bliss GVS Pharma) and is part of a broader restructuring, indicating potential future growth and consolidation.
The company has successfully completed an acquisition, making a target company its wholly-owned subsidiary, which is a positive development for corporate restructuring and future strategic moves.
Anupam Rasayan India Limited has completed the acquisition of 1,000 equity shares, representing 100% of the paid-up equity share capital, of Mates Visa Consultancy Private Limited. This acquisition, executed on July 17, 2026, makes Mates Visa Consultancy a wholly-owned subsidiary of Anupam Rasayan.
The Target, incorporated on May 25, 2022, is engaged in immigration, visa, and overseas education/travel consultancy services. Its turnover for FY 2025-26 was approximately ₹0.31 crore (INR 31.40 lakh).
The acquisition is part of a group restructuring exercise to rationalize the company's investments, including its proposed acquisition of equity shares in Bliss GVS Pharma Limited. Mates Visa Consultancy will act as a person acting in concert (PAC) with Anupam Rasayan for the proposed acquisition of Bliss GVS Pharma Limited shares.
The aggregate consideration for the acquisition was ₹10,000, with shares acquired at ₹10 per equity share. The acquisition does not fall within related party transactions, and the promoter/promoter group/group companies have no interest in the Target. The Target's board and shareholders have passed resolutions to amend its objects to align with Anupam Rasayan's Memorandum of Association and is in the process of changing its name.
What to do with a filing like this
Anupam Rasayan India Limited filed this with the NSE as a statutory disclosure, categorised under acquisition. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Anupam Rasayan India Limited. Read the original for the full detail.